Updated Jul 16, 2026
Brigido Stephen is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Stephen Brigido is a corporate executive known for his role as President of Functional Regeneration at Celularity Inc, a biotechnology company focused on regenerative medicine. His work involves overseeing the development of innovative therapies derived from placental cells.
| Role | Pres., Functional Regeneration |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-15 | CELU | Celularity Inc | F — Tax withholding / forfeiture | 268 | $1.28 | $343 |
| 2026-04-15 | CELU | Celularity Inc | M — Option exercise | 821 | $0.00 |
Stephen Brigido is a corporate executive known for his role as President of Functional Regeneration at Celularity Inc, a biotechnology company focused on regenerative medicine. His work involves overseeing the development of innovative therapies derived from placental cells.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Brigido Stephen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.